Trially wants to transform $22.6B clinical trial industry
Trially, a health tech startup in Kansas City, wants to modernize the clinical trial recruitment process with an artificial intelligence platform. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Grace Mayer Source Type: news
England's NHS Clinics No Longer Offering Puberty Blockers to Trans Youth
(MedPage Today) -- England's National Health Service (NHS) will no longer offer puberty-blocking medications to youths under 18 in its clinics, unless they are enrolled in clinical trials planned for the end of the year.
"Puberty suppressing hormones... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 14, 2024 Category: Psychiatry Source Type: news
Trialbee's Jamie Goldfarb to Lead Discussion on Defining Success and Enhancing Collaboration in Clinical Trials at Patients as Partners in Clinical Research Conference
2023 Linnea Olson Patient Advocate of the Year award winner will also serve as an advocacy mentor at the conference (March 20-22, Philadelphia, PA) CHAPEL HILL, N.C. and MALMÖ, Sweden, March 14, 2024 /PRNewswire-PRWeb/ -- Trialbee, the global leader in technology-driven patient... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 14, 2024 Category: Pharmaceuticals Source Type: news
£ 2.2 million for clinical trial to improve general practice response to men and children affected by domestic abuse
A new clinical trial of a general practice programme to improve the identification and referral of men and children affected by domestic abuse begins in May thanks to a £ 2.2 million National Institute for Health and Care Research (NIHR) award to University of Bristol researchers, in partnership with Oxford University and the social enterprise IRISi. (Source: University of Bristol news)
Source: University of Bristol news - March 14, 2024 Category: Universities & Medical Training Tags: Health, Grants and Awards, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Faculty of Health Sciences, Bristol Medical School, Institutes, Institutes, Bristol Population Health Science Institute Source Type: news
Clinical Data Analytics Solutions Market Projected to Reach USD 7.5 Billion by 2030, Driven by AI Integration and Increase in Clinical Trials
DUBLIN, March 13, 2024 /PRNewswire/ -- The "Clinical Data Analytics Solutions Market Size, Share & Trends Analysis Report By Deployment (Cloud-based, On-premise), By Application (Clinical Decision Support, Clinical Trials, Regulatory Compliance), By Region, And Segment Forecasts, 2024 -... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 14, 2024 Category: Pharmaceuticals Tags: MRR Source Type: news
Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile
RAMAT GAN, Israel, March 13, 2024 /PRNewswire/ -- Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 13, 2024 Category: Pharmaceuticals Tags: TRI PDT Source Type: news
Wearable Sensors in Clinical Trials: Data System Integrity Considerations, Upcoming Webinar Hosted by Xtalks
In this free webinar, hear from experts across diverse fields (technology, pharmaceutical industry and digital health) who will discuss data system requirements to deliver digital health technologies with high integrity and trust. Attendees will understand the importance of data system... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 13, 2024 Category: Pharmaceuticals Source Type: news
Durham research firm acquired by Colorado company
The business combination targets growing demand for mobile clinical trials and will likely lead to job growth locally. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 13, 2024 Category: Biotechnology Authors: Zac Ezzone Source Type: news
ClearPoint posts revenue increases in Q4, year-end 2023
ClearPoint Neuro posted increases in revenue in its fourth quarter and full-year 2023, citing an uptick in sales related to customer-sponsored preclinical and clinical trials.
The company’s total revenue in the fourth quarter (end-December 31) was $6.8 million, up 32% from $5.2 million for the same period last year. The company’s biologics and drug delivery revenue increased 76% to $4.1 million for the quarter, up $2.3 million from the fourth quarter of 2022.
In addition, the company posted a total revenue of $24 million for full-year 2023, up from $20.6 million for full-year 2022. ClearPoint’s biologics and drug d...
Source: AuntMinnie.com Headlines - March 13, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Merck to Test Single-dose Regimen Of HPV Vaccine Gardasil 9 Merck to Test Single-dose Regimen Of HPV Vaccine Gardasil 9
Merck& Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and safety of a...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 13, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
The Role of Disclosures: Helping to Understand Oncology Clinical Trial Endpoints
FDA Research Focused on Direct-to-Consumer Television Advertising (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 12, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
AI or Bye: Revolutionizing Clinical Trials with Cutting-Edge Technology
Jeeva Clinical Trials is revolutionizing drug development by integrating AI and automated workflows into clinical trials, significantly reducing the time and cost of bringing treatments to market. Led by Dr. Harsha Rajasimha, the platform emphasizes efficiency and broadens participant... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 12, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Novel molecules from generative AI to Phase II
There are thousands of diseases worldwide with no cure or available treatments. Traditional drug discovery and development takes decades and billions of dollars and more than 90% of these drugs fail in clinical trials. The emergence of artificial intelligence (AI) holds promise for streamlining and improving the entire process. However, ushering in a new era of AI-driven drug discovery requires costly and lengthy validation in preclinical cell, tissue, and animal models and human clinical trials. (Source: World Pharma News)
Source: World Pharma News - March 12, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Acadia to Stop Trials Of Antipsychotic Drug After It Fails Schizophrenia Study Acadia to Stop Trials Of Antipsychotic Drug After It Fails Schizophrenia Study
Acadia Pharmaceuticals said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative...Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2024 Category: Consumer Health News Tags: Psychiatry Source Type: news
FL Jury Fails to Agree on J & J Talc Verdict
Bob Sugarman sued Johnson & Johnson, claiming the company’s talc products caused the death of his wife, Marilyn Seskin, MD. The case has ended in a mistrial after the jury was unable to agree on a verdict.
The jury note the judge read aloud in court stated: “We are hopelessly deadlocked with absolutely, positively no way to resolve it.”
The closely watched trial was held in Florida’s Circuit Court for the 11th Judicial Circuit in Miami-Dade County. It was the first talc powder trial against J&J in 3 years after litigation had been paused during the company’s failed bankruptcy proceedings...
Source: Asbestos and Mesothelioma News - March 11, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos Exposure Companies johnson Lawsuit Legal talc Talcum Powder Verdict Source Type: news
